Complete Filing Data
RetinalGenix Technologies Inc. reported Stockholders Equity of -$1.07 million for FY2022.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean RetinalGenix Technologies Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Net Income Loss | -$4.3M | -$2.1M | -$3.9M | -$2.2M | -$2.1M |
| Operating Expenses | $4.3M | $2.1M | $3.9M | $2.2M | $2.1M |
| General And Administrative Expense | $1.3M | $898.7K | $807.4K | $1.1M | $1.4M |
| Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities | $3.6M | $1.6M | $3.7M | $1.0M | $655.7K |
| Research And Development Expense | $373.3K | $524.2K | $680.3K | $431.6K | |
| Interest Expense | $3.8K | $5.1K | $2.6K | ||
| Research And Development Expense Excluding Acquired In Process Cost | $524.2K | $809.3K | $747.8K | ||
| Interest Expense Nonoperating | $3.8K | $3.8K | |||
| Research And Development Asset Acquired Other Than Through Business Combination Written Off | $2.0M | ||||
| Acquired Inprocess Research And Development Through Issuance Of Common Stock | $2.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$568.8K | -$649.4K | -$587.3K | -$644.3K | -$663.6K | -$2.1M | -$686.5K | -$352.1K | -$510.6K | -$2.5M | -$359.3K | -$375.2K | -$551.0K | -$534.9K | -$683.7K | -$567.1K | -$430.9K | -$466.8K |
| Operating Expenses | $567.8K | $648.3K | $586.4K | $643.3K | $662.7K | $2.1M | $685.5K | $351.2K | $509.7K | $2.5M | $357.9K | $373.7K | $549.8K | $534.9K | $567.1K | |||
| General And Administrative Expense | $270.2K | $383.7K | $341.2K | $244.1K | $368.7K | $329.0K | $167.0K | $120.1K | $203.2K | $201.1K | $167.4K | $161.2K | $293.9K | $288.6K | ||||
| Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities | $400.0K | $2.0M | $433.1K | $278.4K | ||||||||||||||
| Research And Development Expense | $20.5K | $14.4K | $13.2K | $103.0K | $82.9K | $83.1K | $152.6K | $135.4K | $200.9K | $159.9K | $98.9K | |||||||
| Interest Expense | $960.00 | $960.00 | $960.00 | $960.00 | $1.3K | $1.5K | $1.5K | $1.2K | ||||||||||
| Research And Development Expense Excluding Acquired In Process Cost | $103.0K | $82.9K | $83.1K | $89.8K | $152.6K | $227.9K | $198.5K | $157.5K | $200.9K | |||||||||
| Interest Expense Nonoperating | $958.00 | $1.1K | $909.00 | $960.00 | $960.00 | $960.00 | $960.00 | $960.00 | ||||||||||
| Research And Development Asset Acquired Other Than Through Business Combination Written Off | $2.0M | |||||||||||||||||
| Acquired Inprocess Research And Development Through Issuance Of Common Stock |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Stockholders Equity | -$1.1M | -$464.7K | -$80.4K | $24.2K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $38.00 | $4.9K | $2.2K | $54.4K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $6.1K | -$38.00 | -$4.9K | $2.7K | -$52.2K | |
| Retained Earnings Accumulated Deficit | -$11.1M | -$9.0M | -$5.1M | -$2.9M | ||
| Liabilities And Stockholders Equity | $156.00 | $294.00 | $4.9K | $61.1K | ||
| Liabilities | $1.4M | $1.1M | $469.6K | $141.4K | ||
| Common Stock Value | $1.8K | $1.8K | $1.4K | $4.1K | ||
| Assets | $156.00 | $294.00 | $4.9K | $61.1K | ||
| Interest Payable Current | $11.6K | $7.8K | $2.6K | |||
| Assets Current | $38.00 | $4.9K | $61.1K | |||
| Loans Payable Current | $49.0K | $49.0K | $73.0K | |||
| Accounts Payable And Accrued Liabilities Current | $884.9K | $475.5K | $251.3K | |||
| Cash And Cash Equivalents At Carrying Value | $38.00 | $4.9K | $2.2K | |||
| Property Plant And Equipment Net | $156.00 | $256.00 | ||||
| Liabilities Current | $1.4M | |||||
| Accounts Payable Current | $141.4K | |||||
| Cash | $38.00 | $4.9K | $2.2K | |||
| Stock Issued During Period Value Settlement Of Accounts Payable | $150.0K | |||||
| Operating Lease Right Of Use Asset | ||||||
| Operating Lease Liability Noncurrent | ||||||
| Operating Lease Liability Current | ||||||
| Notes Payable Current | ||||||
| Finance Lease Right Of Use Asset Amortization | $854.00 | |||||
| Preferred Stock Value | $300.00 | |||||
| Preferred Stock Shares Subscribed But Unissued Subscriptions Receivable | 300.00 | |||||
| Change In Stockholders Refund Payable | $25.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$2.2M | -$2.0M | -$1.7M | -$1.5M | -$1.9M | -$1.8M | -$1.5M | -$1.4M | -$1.1M | -$1.8M | -$1.5M | -$1.1M | -$675.2K | -$724.3K | -$412.7K | -$35.7K | -$254.5K | $134.0K | -$128.8K | -$10.6K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $92.00 | $839.00 | $3.7K | $6.1K | $79.1K | $86.9K | $50.4K | $0.00 | $44.00 | $1.9K | $7.5K | $3.6K | $27.00 | $2.6K | $36.6K | $1.3K | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$2.3K | $50.4K | $7.4K | -$2.4K | |||||||||||||||||||
| Retained Earnings Accumulated Deficit | -$17.2M | -$16.7M | -$16.0M | -$15.4M | -$14.6M | -$13.9M | -$13.3M | -$10.6M | -$9.9M | -$9.5M | -$8.3M | -$5.8M | -$4.7M | ||||||||||
| Liabilities And Stockholders Equity | $7.0K | $8.4K | $11.9K | $14.9K | $88.9K | $87.0K | $50.5K | $225.00 | $2.1K | $7.7K | $3.9K | $27.00 | $36.6K | ||||||||||
| Liabilities | $2.2M | $2.0M | $1.7M | $1.5M | $1.9M | $1.9M | $1.6M | $1.1M | $1.8M | $1.5M | $1.1M | $675.2K | $449.3K | ||||||||||
| Common Stock Value | $1.9K | $1.9K | $1.9K | $1.9K | $1.8K | $1.8K | $1.8K | $1.8K | $1.8K | $1.8K | $1.7K | $1.5K | $4.2K | ||||||||||
| Assets | $7.0K | $8.4K | $11.9K | $14.9K | $88.9K | $87.0K | $50.5K | $225.00 | $2.1K | $7.7K | $3.9K | $27.00 | $36.6K | ||||||||||
| Interest Payable Current | $18.3K | $17.4K | $16.4K | $15.4K | $14.5K | $13.5K | $12.6K | $10.6K | $9.7K | $8.7K | $6.8K | $5.5K | $1.2K | ||||||||||
| Assets Current | $92.00 | $839.00 | $3.7K | $6.1K | $79.1K | $86.9K | $50.4K | $0.00 | $44.00 | $1.9K | $7.5K | $3.6K | $27.00 | $36.6K | |||||||||
| Loans Payable Current | $49.0K | $49.0K | $49.0K | $49.0K | $49.0K | $49.0K | $49.0K | $49.0K | $49.0K | $48.0K | $73.0K | $73.0K | |||||||||||
| Accounts Payable And Accrued Liabilities Current | $1.0M | $1.0M | $923.3K | $922.1K | $885.6K | $862.5K | $813.6K | $751.4K | $697.1K | $634.2K | $366.7K | ||||||||||||
| Cash And Cash Equivalents At Carrying Value | $44.00 | $1.9K | $7.5K | $3.6K | $27.00 | $36.6K | $30.1K | $54.4K | |||||||||||||||
| Property Plant And Equipment Net | $31.00 | $56.00 | $81.00 | $106.00 | $131.00 | $181.00 | $206.00 | $231.00 | $282.00 | ||||||||||||||
| Liabilities Current | $2.2M | $2.0M | $1.7M | $1.5M | $1.9M | ||||||||||||||||||
| Accounts Payable Current | $339.6K | $251.3K | $210.9K | ||||||||||||||||||||
| Cash | $44.00 | $1.9K | $7.5K | $3.6K | $27.00 | $36.6K | $30.1K | $54.4K | |||||||||||||||
| Stock Issued During Period Value Settlement Of Accounts Payable | $150.0K | ||||||||||||||||||||||
| Operating Lease Right Of Use Asset | $4.9K | $5.6K | $6.2K | $6.8K | $7.7K | ||||||||||||||||||
| Operating Lease Liability Noncurrent | $6.0K | $6.2K | $6.4K | $6.5K | $7.0K | ||||||||||||||||||
| Operating Lease Liability Current | $988.00 | $988.00 | $988.00 | $988.00 | $662.00 | ||||||||||||||||||
| Notes Payable Current | $49.0K | $49.0K | |||||||||||||||||||||
| Finance Lease Right Of Use Asset Amortization | $641.00 | ||||||||||||||||||||||
| Preferred Stock Value | $300.00 | ||||||||||||||||||||||
| Preferred Stock Shares Subscribed But Unissued Subscriptions Receivable | 300.00 | ||||||||||||||||||||||
| Change In Stockholders Refund Payable |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Share Based Compensation | $2.6M | $664.2K | $259.3K | $307.9K | $220.2K |
| Net Cash Provided By Used In Operating Activities | -$741.9K | -$451.7K | -$199.3K | -$1.2M | -$1.4M |
| Net Cash Provided By Used In Financing Activities | $748.0K | $451.6K | $194.7K | $1.2M | $1.4M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $409.4K | $225.2K | $109.9K | $136.2K | |
| Increase Decrease In Interest Payable Net | $3.8K | $5.1K | $2.6K | ||
| Proceeds From Issuance Of Common Stock | $503.1K | $60.5K | $1.1M | $1.4M | |
| Proceeds From Related Party Debt | $34.9K | $451.6K | $109.2K | $73.0K | |
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | $151.00 | $51.00 | |||
| Proceeds From Warrant Exercises | $25.0K | $13.5K | |||
| Proceeds From Stock Options Exercised | $210.0K | ||||
| Payments To Acquire Machinery And Equipment | $307.00 | ||||
| Increase Decrease In Operating Lease Liability | -$157.00 | ||||
| Increase Decrease In Other Current Assets | -$43.8K | $43.8K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $277.2K | $250.2K | $231.9K | $296.3K | $211.0K | $1.7M | $428.7K | $78.5K | $78.5K | $70.7K | $55.1K | $55.1K | $55.1K | $86.3K | $55.1K | |
| Net Cash Provided By Used In Operating Activities | -$187.2K | -$163.8K | -$77.6K | -$96.8K | ||||||||||||
| Net Cash Provided By Used In Financing Activities | $184.9K | $214.2K | $85.0K | $94.4K | ||||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $1.3K | $78.6K | $158.7K | $11.2K | ||||||||||||
| Increase Decrease In Interest Payable Net | $960.00 | $960.00 | $960.00 | $1.5K | ||||||||||||
| Proceeds From Issuance Of Common Stock | $60.5K | |||||||||||||||
| Proceeds From Related Party Debt | $34.9K | $64.2K | $85.0K | $33.9K | ||||||||||||
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | $307.00 | $307.00 | $276.00 | $251.00 | $226.00 | $201.00 | $176.00 | $126.00 | $101.00 | $52.00 | $25.00 | |||||
| Proceeds From Warrant Exercises | $25.0K | |||||||||||||||
| Proceeds From Stock Options Exercised | $150.0K | |||||||||||||||
| Payments To Acquire Machinery And Equipment | ||||||||||||||||
| Increase Decrease In Operating Lease Liability | -$154.00 | |||||||||||||||
| Increase Decrease In Other Current Assets |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Diluted EPS * | -$0.24 | -$0.12 | -$0.25 | -$0.05 | -$0.05 |
| Preferred Stock Shares Authorized | 40.0M | 40.0M | 40.0M | 40.0M | |
| Common Stock Shares Authorized | 80.0M | 80.0M | 80.0M | 80.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 17.9M | 17.4M | 15.6M | 41.2M | |
| Earnings Per Share Basic | $-0.24 | $-0.12 | $-0.25 | $-0.05 | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Diluted Shares Outstanding | 17.9M | 17.4M | 15.6M | ||
| Common Stock Shares Outstanding | 17.6M | 17.3M | 14.2M | 40.7M | |
| Common Stock Shares Issued | 17.6M | 17.3M | 14.2M | 40.7M | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 41.2M | 39.7M | |||
| Shares Issued For Repayment Of Debt Value | 390.4K | 358.1K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q3 2020 | Q4 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.03 | -$0.03 | -$0.03 | -$0.04 | -$0.04 | -$0.12 | -$0.04 | -$0.02 | -$0.03 | -$0.15 | -$0.02 | -$0.01 | -$0.01 | ||||
| Preferred Stock Shares Authorized | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | |||
| Common Stock Shares Authorized | 80.0M | 80.0M | 80.0M | 80.0M | 80.0M | 80.0M | 80.0M | 80.0M | 80.0M | 80.0M | 80.0M | 80.0M | 80.0M | 80.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Shares Outstanding Basic | 18.6M | 18.3M | 18.5M | 18.0M | 17.9M | 17.7M | 17.3M | 17.3M | 17.3M | 16.6M | 14.5M | 14.3M | 41.0M | 41.0M | |||
| Earnings Per Share Basic | $-0.03 | $-0.03 | $-0.03 | $-0.04 | $-0.04 | $-0.12 | $-0.04 | $-0.02 | $-0.03 | $-0.15 | $-0.02 | $-0.03 | $-0.01 | $-0.01 | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Diluted Shares Outstanding | 18.6M | 18.3M | 18.5M | 18.0M | 17.9M | 17.7M | 17.3M | 17.3M | 17.3M | 16.6M | 14.5M | ||||||
| Common Stock Shares Outstanding | 18.6M | 18.6M | 18.5M | 18.5M | 18.1M | 17.9M | 17.9M | 17.6M | 17.3M | 17.3M | 16.7M | 14.6M | 41.9M | ||||
| Common Stock Shares Issued | 18.6M | 18.6M | 18.5M | 18.5M | 18.1M | 17.9M | 17.9M | 17.6M | 17.3M | 17.3M | 16.7M | 14.6M | 41.9M | ||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 41.8M | 40.0M | |||||||||||||||
| Shares Issued For Repayment Of Debt Value | 390.4K | 358.1K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.6M | $664.2K | $259.3K | $307.9K | $220.2K |
| Stock Issued During Period Value New Issues | $503.1K | $60.5K | $1.1M | $1.4M | |
| Additional Paid In Capital | $9.7M | $7.9M | $4.6M | $2.8M | |
| Other Noncash Expense | $664.9K | $1.2M | $548.1K | $343.1K | |
| Stock Issued1 | $666.0K | $1.1M | $939.8K | $390.4K | $358.1K |
| Depreciation | $100.00 | $100.00 | $51.00 | ||
| Stock Repurchased And Retired During Period Value | $666.0K | $1.1M | $939.8K | $390.4K | |
| Stock Issued During Period Value Stock Options Exercised | $210.0K | ||||
| Stock Issued During Period Shares Stock Options Exercised | |||||
| Stock Issued During Period Value Other | $13.5K | ||||
| Stock Repurchased And Retired During Period Shares | 939.8K | 390.4K | |||
| Stock Issued During Period Value Warrant And Stock Options Exercised | $50.0K | ||||
| Stock Issued During Period Value Acquisitions | $2.0M | ||||
| Security Deposit | |||||
| Other Noncash Income Expense | -$654.3K | -$561.6K | |||
| Due To Affiliate Current | $427.9K | $142.7K | |||
| Administrative Fees Expense | |||||
| Stock Issued During Period Shares Acquisitions | 2.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $277.2K | $250.2K | $231.9K | $296.3K | $211.0K | $1.7M | $428.7K | $78.5K | $78.5K | $70.7K | $55.1K | $55.1K | $55.1K | $86.3K | $111.5K | $55.1K | $55.1K | $55.1K | |
| Stock Issued During Period Value New Issues | $100.0K | $86.0K | $305.0K | $100.0K | $150.0K | $60.5K | $190.0K | $263.4K | $398.1K | $416.7K | $257.7K | $377.0K | |||||||
| Additional Paid In Capital | $15.1M | $14.7M | $14.3M | $14.1M | $12.7M | $12.1M | $11.7M | $9.5M | $8.1M | $8.0M | $7.3M | $5.2M | $4.3M | ||||||
| Other Noncash Expense | $165.4K | $169.7K | $194.9K | $210.7K | |||||||||||||||
| Stock Issued1 | |||||||||||||||||||
| Depreciation | $25.00 | $25.00 | $25.00 | ||||||||||||||||
| Stock Repurchased And Retired During Period Value | $950.1K | $353.4K | $390.4K | ||||||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $60.0K | $150.0K | |||||||||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 20.0K | 150.0K | |||||||||||||||||
| Stock Issued During Period Value Other | $150.0K | $13.5K | |||||||||||||||||
| Stock Repurchased And Retired During Period Shares | |||||||||||||||||||
| Stock Issued During Period Value Warrant And Stock Options Exercised | $50.0K | ||||||||||||||||||
| Stock Issued During Period Value Acquisitions | $2.0M | ||||||||||||||||||
| Security Deposit | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | ||||||||||||||
| Other Noncash Income Expense | |||||||||||||||||||
| Due To Affiliate Current | $561.9K | $215.4K | |||||||||||||||||
| Administrative Fees Expense | $293.9K | $413.2K | |||||||||||||||||
| Stock Issued During Period Shares Acquisitions |
Most recent annual filing with the SEC: March 31, 2025
Data sourced from SEC EDGAR public filings as of August 6, 2026.